47 results on '"de Ferranti, Sarah"'
Search Results
2. Dyslipidemia Among Adults With Congenital Heart Disease
3. Helping young women go red: Harnessing the power of personal and digital information to prevent heart disease
4. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes
5. Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry
6. Cardiovascular health decline in adolescent girls in the NGHS cohort, 1987–1997
7. Young Women's Perceptions of Heart Disease Risk
8. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial
9. Cardiovascular Risk and Cardiovascular Health Behaviours in the Transition From Childhood to Adulthood
10. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry
11. Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population
12. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease
13. Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events
14. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
15. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
16. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
17. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel
18. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease
19. Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice
20. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians
21. Kawasaki disease and immunisation: A systematic review
22. Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices
23. 52 - Evaluating murmurs, chest pain, and syncope
24. 44 - Preventive cardiology
25. Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis
26. Nutrition in Children and Adolescents
27. Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia
28. Adolescent Perceptions of Cholesterol Screening Results: “Young Invincibles” or Developing Adults?
29. Familial hypercholesterolemia in children and adolescents: A clinical perspective
30. Treatment decision making for adolescents with familial hypercholesterolemia: Role of family history and past experiences
31. Adherence to lipid-lowering therapy and reaching treatment goals in youth seen in a preventive cardiology clinic
32. Vascular Health in Kawasaki Disease
33. Childhood Cholesterol Disorders: The Iceberg Base or Nondisease?
34. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
35. Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
36. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients: Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
37. Contributors
38. Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers
39. C-reactive protein: a nontraditional serum marker of cardiovascular risk
40. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions
41. B-PO02-041 ACTIVITY DURING THE COVID-19 PANDEMIC IN CHILDREN WITH CARDIAC RHYTHM MANAGEMENT DEVICES
42. CARDIOVASCULAR HEALTH CHARACTERISTICS IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE
43. Improving Cardiovascular Health in a Pediatric Preventive Cardiology Practice
44. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic
45. Homozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry†
46. QUALITY IMPROVEMENT IN OUTPATIENT PEDIATRIC CARDIOLOGY: EARLY EXPERIENCE WITH THE AMERICAN COLLEGE OF CARDIOLOGY, QUALITY NETWORK
47. Pediatric Familial Hypercholesterolemia: Children and Adolescents Enrolled in the CAscade SCreening for Awareness
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.